ELV Relative Valuation
ELV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ELV is overvalued; if below, it's undervalued.
Historical Valuation
Elevance Health Inc (ELV) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.11 is considered Undervalued compared with the five-year average of 13.75. The fair price of Elevance Health Inc (ELV) is between 349.35 to 429.18 according to relative valuation methord. Compared to the current price of 333.49 USD , Elevance Health Inc is Undervalued By 4.54%.
Relative Value
Fair Zone
349.35-429.18
Current Price：333.49
4.54%
Undervalued
12.11
PE
1Y
3Y
5Y
Trailing
Forward
9.42
EV/EBITDA
Elevance Health Inc. (ELV) has a current EV/EBITDA of 9.42. The 5-year average EV/EBITDA is 10.27. The thresholds are as follows: Strongly Undervalued below 8.09, Undervalued between 8.09 and 9.18, Fairly Valued between 11.35 and 9.18, Overvalued between 11.35 and 12.44, and Strongly Overvalued above 12.44. The current Forward EV/EBITDA of 9.42 falls within the Historic Trend Line -Fairly Valued range.
10.44
EV/EBIT
Elevance Health Inc. (ELV) has a current EV/EBIT of 10.44. The 5-year average EV/EBIT is 11.39. The thresholds are as follows: Strongly Undervalued below 8.99, Undervalued between 8.99 and 10.19, Fairly Valued between 12.59 and 10.19, Overvalued between 12.59 and 13.79, and Strongly Overvalued above 13.79. The current Forward EV/EBIT of 10.44 falls within the Historic Trend Line -Fairly Valued range.
0.36
PS
Elevance Health Inc. (ELV) has a current PS of 0.36. The 5-year average PS is 0.62. The thresholds are as follows: Strongly Undervalued below 0.39, Undervalued between 0.39 and 0.50, Fairly Valued between 0.74 and 0.50, Overvalued between 0.74 and 0.85, and Strongly Overvalued above 0.85. The current Forward PS of 0.36 falls within the Strongly Undervalued range.
11.14
P/OCF
Elevance Health Inc. (ELV) has a current P/OCF of 11.14. The 5-year average P/OCF is 13.76. The thresholds are as follows: Strongly Undervalued below 8.61, Undervalued between 8.61 and 11.19, Fairly Valued between 16.34 and 11.19, Overvalued between 16.34 and 18.92, and Strongly Overvalued above 18.92. The current Forward P/OCF of 11.14 falls within the Undervalued range.
12.04
P/FCF
Elevance Health Inc. (ELV) has a current P/FCF of 12.04. The 5-year average P/FCF is 14.52. The thresholds are as follows: Strongly Undervalued below 9.27, Undervalued between 9.27 and 11.89, Fairly Valued between 17.14 and 11.89, Overvalued between 17.14 and 19.76, and Strongly Overvalued above 19.76. The current Forward P/FCF of 12.04 falls within the Historic Trend Line -Fairly Valued range.
Elevance Health Inc (ELV) has a current Price-to-Book (P/B) ratio of 1.68. Compared to its 3-year average P/B ratio of 2.58 , the current P/B ratio is approximately -34.72% higher. Relative to its 5-year average P/B ratio of 2.71, the current P/B ratio is about -37.92% higher. Elevance Health Inc (ELV) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 5.45%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 6.60% , the current FCF yield is about -100.00% lower.
1.68
P/B
Median3y
2.58
Median5y
2.71
5.12
FCF Yield
Median3y
5.45
Median5y
6.60
Competitors Valuation Multiple
The average P/S ratio for ELV's competitors is , providing a benchmark for relative valuation. Elevance Health Inc Corp (ELV) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 12.33%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ELV decreased by 9.60% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 45.15B to 50.71B.
The secondary factor is the Margin Expansion, contributed 4.93%to the performance.
Overall, the performance of ELV in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Elevance Health Inc (ELV) currently overvalued or undervalued?
What is Elevance Health Inc (ELV) fair value?
How does ELV's valuation metrics compare to the industry average?
What is the current P/B ratio for Elevance Health Inc (ELV) as of Dec 05 2025?
What is the current FCF Yield for Elevance Health Inc (ELV) as of Dec 05 2025?
What is the current Forward P/E ratio for Elevance Health Inc (ELV) as of Dec 05 2025?